![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/22 | (2006.01) |
A61K 9/0048 | (2013.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/12 | (2013.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 31/194 | (2013.01) | ||
A61K 47/02 | (2006.01) | ||
A61K 47/02 | (2013.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 38/2292 | (2013.01) | ||
A61K 31/194 | (2006.01) | ||
A61K 9/08 | (2013.01) | ||
A61P 27/02 | (2006.01) | ||
A61P 27/02 | (2018.01) |
(11) | Number of the document | 3338792 |
(13) | Kind of document | T |
(96) | European patent application number | 16837270.4 |
Date of filing the European patent application | 2016-08-12 | |
(97) | Date of publication of the European application | 2018-06-27 |
(45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2016/008924 |
Date | 2016-08-12 |
(87) | Number | WO 2017/030328 |
Date | 2017-02-23 |
(30) | Number | Date | Country code |
20150116089 | 2015-08-18 | KR |
(72) |
KANG, Sin Wook , KR
KIM, Kyoungsun , KR
SUNG, Ji Hye , KR
|
(73) |
HLB Therapeutics Co., Ltd. ,
22F, 248 Jeongjail-ro
Bundang-gu, Seongnam-si, Gyeonggi-do 13554,
KR
|
(54) | CORNEAL DAMAGE PREVENTION/TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AND CITRIC ACID AS ACTIVE INGREDIENTS |
CORNEAL DAMAGE PREVENTION/TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AND CITRIC ACID AS ACTIVE INGREDIENTS |